<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540342</url>
  </required_header>
  <id_info>
    <org_study_id>Z171100000417021</org_study_id>
    <nct_id>NCT03540342</nct_id>
  </id_info>
  <brief_title>Evaluation of One-stop Strategy of EVAR and PCI</brief_title>
  <official_title>Evaluation of the Strategy of &quot;One-stop&quot; Endovascular Treatment for Concomitant Coronary Artery Disease and Aortic Atherosclerotic Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences, Fuwai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences, Fuwai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the safety and effectiveness of the &quot;one-stop&quot; endovascular
      intervention strategy for patients with concomitant coronary artery disease and aortic
      atherosclerotic disease. It is a registration study, which will consecutively enroll at least
      50 patients with at least 30 subjects receiving one-stop strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a registration study, at least 50 patients will be consecutively enrolled and then be
      allocated into one-stop strategy group or staging strategy group with at least 30 subjects
      receiving one-stop strategy. In one stop strategy group, percutaneous coronary intervention
      (PCI) will be performed on the same operating table immediately after the endovascular aortic
      repair (EVAR). In staging strategy group, PCI will be performed several days after EVAR. The
      safety and effectiveness will be assessed between the two groups untill 1 year after the
      operation. The economic index will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment-Emergent Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>The incidence of a composite endpoint of all-cause mortality, myocardial infarction, rupture of aorta, hematoma, bleeding events (BARC≥2 grade), pseudoaneurysm, stent thrombosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative success rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average in-patient time</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average cost during hospitalization</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Aortic Atherosclerotic Disease</condition>
  <arm_group>
    <arm_group_label>One stop strategy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous coronary intervention (PCI) will be performed on the same operating table immediately after the endovascular aortic repair (EVAR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Staging strategy group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PCI will be performed several days after EVAR</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One stop strategy group</intervention_name>
    <description>Percutaneous coronary intervention (PCI) will be performed on the same operating table immediately after the endovascular aortic repair (EVAR)</description>
    <arm_group_label>One stop strategy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged from 18 years to 75years, male or female;

          -  Aortic atherosclerotic disease with the indication of EVAR;

          -  Coronary heart disease with the indication of PCI;

          -  Provided informed consent.

        Exclusion Criteria:

          -  Acute aortic dissection

          -  Acute coronary syndrome

          -  Dysfunction of coagulation system

          -  Patients with gastrointestinal hemorrhage

          -  Known allergy to contrasts or antiplatelet drugs

          -  Renal dysfunction (GFR≤60ml/min)

          -  Patient with multi-branch coronary preferred CABG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi-Da Tang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Min Yang, MD</last_name>
    <phone>+861088396173</phone>
    <email>13810727489@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kuo Zhang, MD</last_name>
    <phone>+8618813019602</phone>
    <email>kzhang23@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chinese Academy of Medical Sciences, Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Min Yang, MD</last_name>
      <phone>+861088396173</phone>
      <email>13810727489@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Kuo Zhang, MD</last_name>
      <phone>+8618813019602</phone>
      <email>kzhang23@outlook.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>May 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>May 28, 2018</last_update_submitted>
  <last_update_submitted_qc>May 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences, Fuwai Hospital</investigator_affiliation>
    <investigator_full_name>Yi-Da Tang</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>aortic atherosclerotic disease</keyword>
  <keyword>one-stop</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>endovascular aortic repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

